Fortaleza Asset Management’s Amicus Therapeutics FOLD Stock Holding History

Fortaleza Asset Management’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$144K	Sell	9,250 -4,155	-31%	-$62.8K	1.17%	31
2018 Q1	$202K	Buy	13,405 +6,190	+86%	+$94.2K	1.23%	33
2017 Q4	$104K	Hold	7,215	–	–	0.65%	77
2017 Q3	$109K	Hold	7,215	–	–	0.2%	135
2017 Q2	$73K	Buy	+7,215	New	+$58.1K	0.14%	148

Other funds holding FOLD

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fortaleza Asset Management's FOLD Position: Q2 2018 in Review

Fortaleza Asset Management reduced its Amicus Therapeutics (FOLD) stake by 31% in Q2 2018, selling an estimated $62.8K and leaving 9,250 shares worth $144K. The position accounts for 1.17% of the portfolio, ranked #31.

Fortaleza Asset Management first reported a position in FOLD in Q2 2017 and has held it in 5 quarters since. The position peaked at $202K in Q1 2018. 200 funds tracked by Wall St. Rank hold FOLD as of Q2 2018.

Fortaleza Asset Management held 9,250 shares of Amicus Therapeutics worth $144K as of Q2 2018.
Fortaleza Asset Management sold 4,155 Amicus Therapeutics shares in Q2 2018, an estimated $62.8K.
Amicus Therapeutics made up 1.17% of Fortaleza Asset Management's portfolio in Q2 2018, its #31 holding.
Fortaleza Asset Management first reported a position in Amicus Therapeutics in Q2 2017 and has held it in 5 quarters since.
Fortaleza Asset Management's Amicus Therapeutics position peaked at $202K in Q1 2018.
200 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2018.

Based on Fortaleza Asset Management's 13F filing for Q2 2018, filed 17 Jul 2018.